| 注册
首页|期刊导航|中国医学创新|IgA肾病发病机制及治疗新进展

IgA肾病发病机制及治疗新进展

邹皓珍 杨佳 席哲帆 纪瑞 董华

中国医学创新2025,Vol.22Issue(7):169-174,6.
中国医学创新2025,Vol.22Issue(7):169-174,6.DOI:10.3969/j.issn.1674-4985.2025.07.041

IgA肾病发病机制及治疗新进展

New Advances in the Pathogenesis and Treatment of IgA Nephropathy

邹皓珍 1杨佳 1席哲帆 1纪瑞 1董华1

作者信息

  • 1. 滨州医学院附属医院肾内科 山东 滨州 256699
  • 折叠

摘要

Abstract

Immunoglobulin A nephropathy(IgA nephropathy,IgAN)is the most common primary glomerulonephritis worldwide,characterized by a series of pathological changes of immunoglobulin deposition in the mesangial area of the glomerulus and capillary loops where IgA is the main immunoglobulin.Due to the varying clinical manifestations and pathological characteristics among individuals and races,it is necessary to develop comprehensive and individualized plans for patients.In recent years,with in-depth research on the pathogenesis of IgAN,there have been significant gains in targeted therapy.This article briefly describes the pathogenesis of IgAN and provides a review of current IgAN treatment strategies.

关键词

IgA肾病/发病机制/治疗策略

Key words

IgA nephropathy/Pathogenesis/Therapeutic strategy

引用本文复制引用

邹皓珍,杨佳,席哲帆,纪瑞,董华..IgA肾病发病机制及治疗新进展[J].中国医学创新,2025,22(7):169-174,6.

基金项目

山东省医药卫生科技发展计划项目(2016WS0048) (2016WS0048)

中国医学创新

1674-4985

访问量3
|
下载量0
段落导航相关论文